Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 20, Issue 6, Pages 1361-1366
Publisher
Wiley
Online
2018-01-23
DOI
10.1111/dom.13229
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes
- (2018) Milton Packer DIABETES OBESITY & METABOLISM
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin
- (2017) Ulrika Ljung Faxén et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients
- (2017) Cho-Kai Wu et al. Journal of Clinical Lipidology
- Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2
- (2017) Vance B. Matthews et al. JOURNAL OF HYPERTENSION
- A role for PFKFB3 /iPFK2 in metformin suppression of adipocyte inflammatory responses
- (2017) Ting Qi et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney
- (2017) David J. Polhemus et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus
- (2017) Jens Jordan et al. Journal of the American Society of Hypertension
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide causes large and rapid epicardial fat reduction
- (2017) Gianluca Iacobellis et al. Obesity
- Lack of effect of prolonged treatment with liraglutide on cardiac remodeling in rats after acute myocardial infarction
- (2017) Kasper Kyhl et al. PEPTIDES
- Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
- (2017) Shusuke Yagi et al. Diabetology & Metabolic Syndrome
- Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE
- (2017) Camilla Hage et al. Circulation-Cardiovascular Genetics
- Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
- (2017) Tatsuya Fukuda et al. Diabetes Therapy
- Ipragliflozin Reduces Epicardial Fat Accumulation in Non-Obese Type 2 Diabetic Patients with Visceral Obesity: A Pilot Study
- (2017) Tatsuya Fukuda et al. Diabetes Therapy
- Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction
- (2017) Erik B. Schelbert et al. JAMA Cardiology
- Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
- (2016) Hiroaki Kusaka et al. Cardiovascular Diabetology
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits
- (2016) Antonius Baartscheer et al. DIABETOLOGIA
- Heart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial
- (2016) Mark M Smits et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Leptin Mediates High-Fat Diet Sensitization of Angiotensin II–Elicited Hypertension by Upregulating the Brain Renin–Angiotensin System and InflammationNovelty and Significance
- (2016) Baojian Xue et al. HYPERTENSION
- Origin of Aberrant Blood Pressure and Sympathetic Regulation in Diet-Induced ObesityNovelty and Significance
- (2016) Kyungjoon Lim et al. HYPERTENSION
- High-Output Heart Failure
- (2016) Yogesh N.V. Reddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dapagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice
- (2016) Yumiko Chiba et al. PLoS One
- Effects of canagliflozin on body weight and body composition in patients with type 2 diabetes over 104 weeks
- (2016) Lawrence Blonde et al. POSTGRADUATE MEDICINE
- Local Application of Leptin Antagonist Attenuates Angiotensin II–Induced Ascending Aortic Aneurysm and Cardiac Remodeling
- (2016) Danny Ben‐Zvi et al. Journal of the American Heart Association
- Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac FibrosisCLINICAL PERSPECTIVE
- (2015) Anne-Cécile Huby et al. CIRCULATION
- Inhibition of Dipeptidyl Peptidase-4 Impairs Ventricular Function and Promotes Cardiac Fibrosis in High Fat–Fed Diabetic Mice
- (2015) Erin E. Mulvihill et al. DIABETES
- Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis
- (2015) Tracey Gaspari et al. Diabetes & Vascular Disease Research
- Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats
- (2015) Kazi Rafiq et al. DIABETOLOGIA
- Ameliorated pancreatic β cell dysfunction in type 2 diabetic patients treated with a sodium-glucose cotransporter 2 inhibitor ipragliflozin
- (2015) Mitsuyoshi Takahara et al. ENDOCRINE JOURNAL
- Local and systemic effects of the multifaceted epicardial adipose tissue depot
- (2015) Gianluca Iacobellis Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intracellular Na+Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+–Glucose Cotransport
- (2015) Rebekah Lambert et al. Journal of the American Heart Association
- Longitudinal Association between Serum Leptin Concentration and Glomerular Filtration Rate in Humans
- (2015) Claudio Pedone et al. PLoS One
- Leptin restores the insulinotropic effect of exenatide in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and high-fat diet
- (2014) Takeru Sakai et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)
- (2014) Matthew R. Weir et al. CURRENT MEDICAL RESEARCH AND OPINION
- Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: A prospective study
- (2014) Gonzalo Díaz-Soto et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice
- (2014) Dayea Kim et al. DIABETOLOGIA
- Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress
- (2014) Ernesto Martínez-Martínez et al. JOURNAL OF HYPERTENSION
- Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
- (2014) T. D. Pessoa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet
- (2014) Steven P Vickers et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Dipeptidyl peptidase IV inhibitor lowers PPARγ agonist-induced body weight gain by affecting food intake, fat mass, and beige/brown fat but not fluid retention
- (2013) Takahiro Masuda et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Selective leptin resistance revisited
- (2013) Allyn L. Mark AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity
- (2013) Maren Leifheit-Nestler et al. Journal of Translational Medicine
- Increased epicardial fat and plasma leptin in type 1 diabetes independently of obesity
- (2013) G. Iacobellis et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease
- (2012) Sam Cherian et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Association Between Epicardial Fat Thickness and Weight Homeostasis Hormones in Patients With Noncachectic Heart Failure
- (2012) George Karayannis et al. ANGIOLOGY
- Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways
- (2012) Ana M. Briones et al. HYPERTENSION
- Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner
- (2012) S Zhao et al. INTERNATIONAL JOURNAL OF OBESITY
- Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin
- (2012) Jan Bolinder et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet-Induced Obese (DIO) Rats
- (2012) James J. Devenny et al. Obesity
- Leptin’s regulation of obesity-induced cardiac extracellular matrix remodeling
- (2011) Sherma Zibadi et al. Cardiovascular Toxicology
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Regulation of Insulin-Stimulated Glucose Uptake in Rat White Adipose Tissue upon Chronic Central Leptin Infusion: Effects on Adiposity
- (2011) Elena Bonzón-Kulichenko et al. ENDOCRINOLOGY
- Effects of leptin and adiponectin on pancreatic β-cell function
- (2011) Yong-ho Lee et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Epicardial Perivascular Adipose-Derived Leptin Exacerbates Coronary Endothelial Dysfunction in Metabolic Syndrome via a Protein Kinase C-β Pathway
- (2010) Gregory A. Payne et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Neprilysin, obesity and the metabolic syndrome
- (2010) K F Standeven et al. INTERNATIONAL JOURNAL OF OBESITY
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
- (2010) V. Vallon et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mechanisms mediating renal sympathetic activation to leptin in obesity
- (2008) Donald A. Morgan et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Plasma Leptin Levels and Incidence of Heart Failure, Cardiovascular Disease, and Total Mortality in Elderly Individuals
- (2008) W. Lieb et al. DIABETES CARE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More